Tag: mds

Thrombophilia-associated stillbirth risk appears limited to factor V Leiden

Venetoclax plus azacitidine demonstrating efficacy for high-risk myelodysplastic syndromes

bySimon Panand1 others

March 20, 2025

1. In patients with treatment-naive high-risk myelodysplastic syndromes (HR MDS), the use of venetoclax (14 days) plus azacitidine was well ...

#VisualAbstract Oral poly(ADP-ribose) polymerase inhibitors were associated with an increased risk of myelodysplastic syndrome and acute myeloid leukaemia over placebo treatment in patients with cancer

byKathleen Lau

January 22, 2021

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result

Tag: mds

Venetoclax plus azacitidine demonstrating efficacy for high-risk myelodysplastic syndromes

#VisualAbstract Oral poly(ADP-ribose) polymerase inhibitors were associated with an increased risk of myelodysplastic syndrome and acute myeloid leukaemia over placebo treatment in patients with cancer

2MM+ All Access

Look up any US clinician

Recent Reports

The medical literature, distilled daily.

Membership benefits